Brian Schneider

Title: Innovations by Brian Schneider in Lithotripsy Technology

Introduction

Brian Schneider is an accomplished inventor based in Natick, MA (US). He has made significant contributions to the field of medical technology, particularly in lithotripsy systems. With a total of two patents to his name, Schneider's work focuses on improving the efficiency and effectiveness of stone fragment capture during medical procedures.

Latest Patents

Schneider's latest patents include innovative designs for stone fragment capture systems used in lithotripsy devices. These devices consist of a handpiece and a lithotripsy probe that extends from it. The energization source delivers energy to the distal end of the probe, while a suction passage allows for the removal of stone fragments and waste fluid. The capture device features a container with a storage space, an entry port that connects to the handpiece, and an exit port. A capture element is also included to facilitate the collection of stone fragments within the storage space. The method involves fragmenting stones, drawing a vacuum to pull fragments and waste fluid, and depositing the fragments into the capture device.

Career Highlights

Brian Schneider is currently employed at Gyrus Acmi, Inc., where he continues to develop and refine his innovative technologies. His work has significantly impacted the field of lithotripsy, enhancing the capabilities of medical professionals in treating patients with kidney stones.

Collaborations

Throughout his career, Schneider has collaborated with notable colleagues, including Charles Baker and David Bloem. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Brian Schneider's contributions to lithotripsy technology exemplify the importance of innovation in the medical field. His patents and ongoing work at Gyrus Acmi, Inc. continue to advance the effectiveness of treatments for kidney stones, ultimately improving patient outcomes.